173 related articles for article (PubMed ID: 26218449)
1. Radiation dosimetry estimates of (18)F-alfatide II based on whole-body PET imaging of mice.
Wang SY; Bao X; Wang MW; Zhang YP; Zhang YJ; Zhang JP
Appl Radiat Isot; 2015 Nov; 105():1-5. PubMed ID: 26218449
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
4. (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.
Yu C; Pan D; Mi B; Xu Y; Lang L; Niu G; Yang M; Wan W; Chen X
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2021-8. PubMed ID: 26121930
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Garcia A; Mirbolooki MR; Pan ML; Mukherjee J
Nucl Med Biol; 2013 Feb; 40(2):289-94. PubMed ID: 23265670
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
[TBL] [Abstract][Full Text] [Related]
7.
Sadre Momtaz A; Safarnejad F
Phys Med; 2023 Mar; 107():102552. PubMed ID: 36857858
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
[TBL] [Abstract][Full Text] [Related]
9. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
10. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.
Sprague DR; Chin FT; Liow JS; Fujita M; Burns HD; Hargreaves R; Stubbs JB; Pike VW; Innis RB; Mozley PD
J Nucl Med; 2007 Jan; 48(1):100-7. PubMed ID: 17204705
[TBL] [Abstract][Full Text] [Related]
11. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates.
Bélanger MJ; Krause SM; Ryan C; Sanabria-Bohorquez S; Li W; Hamill TG; Burns HD
Nucl Med Commun; 2008 Oct; 29(10):915-9. PubMed ID: 18769310
[TBL] [Abstract][Full Text] [Related]
14. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
15. First Evaluation of PET-Based Human Biodistribution and Dosimetry of
Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M
J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906
[No Abstract] [Full Text] [Related]
16.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and Radiation Dosimetry of
Garg PK; Lokitz SJ; Nazih R; Garg S
J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
[TBL] [Abstract][Full Text] [Related]
18. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution, Tumor Detection, and Radiation Dosimetry of
Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E
J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
